Formulation & Process Development designed for potency, low-dose uniformity, and stability.
01
Every step is designed to generate data that is both scientifically sound and fully compliant with regulatory and security requirements.
Controlled Substances
Secure & Compliant Development for Controlled Substances
Developing controlled substance drug products (Schedules II–IV) requires a partner with the proper licenses, facilities, and expertise to manage heightened regulatory requirements. At CMC Pharma, we are fully licensed with the DEA and state authorities to handle controlled substances and operate under strict security, documentation, and oversight protocols.
Many labs and CDMOs cannot accept controlled substance projects or deprioritize them due to compliance burdens. CMC Pharma provides capacity, speed, and focus to keep your program moving. Our secure facilities, chain-of-custody systems, and audit-ready quality framework ensure your project stays on track without compliance setbacks.
Specialized Facility, Containment & Safety Protocols
- Controlled substances demand more than standard lab practices. CMC Pharma maintains:
- Secure Storage & Controlled Access with restricted entry and 24/7 monitoring.
- Containment Protocols for potent and abuse-liability compounds, including validated cleaning and cross-contamination controls.
- Chain-of-Custody Documentation ensuring every transfer, use, and disposal is recorded for audit readiness.
- Environmental Monitoring & Safety Systems to protect personnel and maintain product integrity.
These measures protect your program, meet DEA and FDA expectations, and provide peace of mind that compliance risks are eliminated.
Documentation, Traceability & Controls
- CMC Pharma manages end-to-end documentation and packaging requirements for controlled substances, including:
- Full traceability from API sourcing to final batch release.
- Audit-ready records covering stability studies, deviations, CAPAs, and regulatory responses.
- Security standards required for controlled substances.
Our integrated QA/QC team ensures your program is always inspection-ready and aligned with regulatory expectations.
Why Controlled Substance Programs Stall — and How CMC Prevents It
- Many controlled substance drug development programs face costly delays due to:
- Vendors lacking DEA licenses or security infrastructure.
- Large CDMOs deprioritizing smaller, early-stage projects.
- Disconnects between laboratory execution and regulatory requirements.
- Missing documentation or inadequate chain-of-custody controls.
CMC Pharma prevents these common roadblocks by offering end-to-end support under one roof: a licensed development laboratory, regulatory expertise embedded into every study, and full manufacturing oversight through CMO qualification and management.
The result: faster timelines, fewer risks, and lower overall costs compared to piecemeal consultants or large, manufacturing-capacity-driven CDMOs. We prioritize your early stage program.
The CMC Pharma Advantage
- CMC Pharma is more than a testing lab, a consultant group, or a manufacturer. We are a nimble, full-service development partner, offering:
- Licensed, secure laboratories capable of controlled substance development.
- Integrated formulation, analytical, and stability services with regulatory alignment.
- Manufacturing enablement through tech transfer and DEA-compliant CMO oversight.
- Embedded regulatory strategy to ensure submission-ready data.
With CMC Pharma, your controlled substance program is executed securely, efficiently, and strategically to ensure compliance without slowing development.
Partner with CMC Pharma
Whether you are advancing a pain management therapy, CNS-active agent, or other controlled substance drug product, CMC Pharma provides the secure infrastructure, expertise, and oversight needed to succeed.
Partner with us to de-risk your controlled substance development, accelerate timelines, and ensure compliance every step of the way.
Send a message
Contact Us Today and find out how CMC Pharma can help you!
Whether you need to develop robust analytical methods or require routine testing. Contact CMC Pharma to learn how we can help you advance your development program.
Send us a message or give us a call at 440-485-1734.